Innovation Deficit: Funds for Neglected Diseases like TB are Falling Short
NEW YORK, Jan. 31, 2023 /PRNewswire/ -- The 2022 G-FINDER Report, released today, reveals that for the year 2021, global funding for the development of critical new health technologies to overcome the world's deadliest neglected diseases remained woefully inadequate and largely stagnant. Specifically, global investments in tuberculosis (TB) research and development (R&D) totaled $723 million in 2021, comparable to...
Guardant Health to integrate Lunit’s AI-based scoring algorithm for PD-L1 into its portfolio to enhance cancer biomarker detection
Powered by Lunit SCOPE PD-L1, the Guardant360 TissueNext PD-L1 test with Guardant Galaxy™ shows improved detection of the biomarker in NSCLC Lunit's AI solution is the first application in Guardant Galaxy, a suite of AI and other technology tools that enhance Guardant Health's portfolio of cancer tests SEOUL, South Korea,...
Zhongchao Inc. Announces Introduction of Indian Anti-influenza Drugs to China
SHANGHAI, Jan. 31, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology and other major diseases, today announced that that Chongqing Xinjiang Pharmaceutical Co., Ltd. ("Xinjiang Pharmaceutical"), one of the China operating entities, of which the Company consolidates the financial results with through certain contractual arrangements,...
Appendix 4C – Q2 FY23 Quarterly Cash Flow Report
Highlights: Expanded participation in ATH434 Phase 2 clinical trial with sites opened for recruitment in Australia, the United States, and Italy Presented compelling bioMUSE data at two prestigious industry conferences Granted a 20-year patent for 100 new compounds targeting Parkinson's and Alzheimer's disease Cash balance on 31 December 2022 of A$25.3M...
AXA Designated Endoscopy and Day Surgery Centre officially unveils
Partnering with EC Healthcare to create one-stop services providing health check-ups, medical examinations and treatments No pre-authorisation required for designated endoscopy and day surgery HONG KONG, Jan. 31, 2023 /PRNewswire/ -- AXA Hong Kong and Macau ("AXA") announced the official launch of the "AXA Designated Endoscopy and Day Surgery Centre" ("the Centre") at the Entertainment Building in Central....
Ascletis Announces U.S. FDA Approval of Conducting a Phase IIa Clinical Trial for ASC10 to Treat Respiratory Syncytial Virus Infection
--Respiratory syncytial virus (RSV) infection treatment remains huge unmet medical needs and there is no effective drug for treatment globally so far --Dosage of 800 mg ASC10, twice daily was selected to conduct a Phase IIa study in patients with RSV infection --Preclinical research showed that ASC10-A is a potent inhibitor...
Delivery of 170,000 Bottles of Azvudine Tablets During Spring Festival to Help Rural Areas Weather the Epidemic
HONG KONG, Jan. 31, 2023 /PRNewswire/ -- In response to the infection peak season of COVID-19 in rural areas that may be brought about by people returning home during Chinese New Year, Fosun Foundation announced on 9 January 2023 the cooperation with Fosun Pharma and Genuine Biotech to donate RMB100 million worth of Azvudine tablets, the oral medication for COVID-19,...
Singleron to present single cell sequencing solutions at the 36th Molecular Biology of Plants Conference
COLOGNE, Germany, Jan. 31, 2023 /PRNewswire/ -- Singleron Biotechnologies, a leader in single cell sequencing, will present at the upcoming 36th Molecular Biology of Plants 2023 (MBP2023) Conference of the Section Plant Physiology and Molecular Biology of the German Society for Plant Sciences (DBG) in Hennef, Germany (February 6-9, 2023). Singleron's single cell workflow and tools can not only investigate how...
Daewoong enters exclusive licensing agreement with CS Pharmaceuticals for Bersiporocin in Idiopathic Pulmonary Fibrosis in the Greater China Region
Daewoong Pharmaceutical to receive up to $76M upfront and development milestone payment plus a double-digit royalties on Net Sales CS Pharmaceuticals will receive exclusive rights for development and commercialization of Bersiporocin for the treatment of IPF and other respiratory indications SEOUL, South Korea, Jan. 31, 2023 /PRNewswire/ -- Daewoong Pharmaceutical(CEO Seng-ho Jeon and Chang-jae Lee)...
PM-International donates €1,872,000 to charity sponsoring 5,200 children around the world
SCHENGEN, Luxembourg, Jan. 31, 2023 /PRNewswire/ -- PM-International is thrilled to announce that its charity arm known as "PM We Care" is pushing the boundaries for 2023 by donating €1,872,000, the most it has ever given, to support the health, education and a good environment for thousands of children in partnership with the international aid organisation World Vision. The...
